Organon & Co
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 40.3% | 42.7% | 41.0% | 41.6% | 41.7% | 43.7% | 44.4% | 45.2% | 46.5% | 49.6% | 46.4% | 45.6% | 47.0% | |
| 59.7% | 57.3% | 59.0% | 58.4% | 58.3% | 56.3% | 55.6% | 54.8% | 53.5% | 50.4% | 53.6% | 54.4% | 53.0% | |
| 9.0% | 8.4% | 6.9% | 7.2% | 7.0% | 8.2% | 6.3% | 6.0% | 5.2% | 6.0% | 6.4% | 5.8% | 5.8% | |
| 32.7% | 16.3% | 26.6% | 27.2% | 26.7% | 16.6% | 27.8% | 28.4% | 25.9% | 28.7% | 29.0% | 27.9% | 27.8% | |
| 44.4% | 37.7% | 33.5% | 34.4% | 33.7% | 37.7% | 34.1% | 34.4% | 31.1% | 34.8% | 35.4% | 33.6% | 33.7% | |
| 15.3% | 19.5% | 25.5% | 24.0% | 24.7% | 18.6% | 21.5% | 20.5% | 22.3% | 15.6% | 18.2% | 20.7% | 19.3% | |
| 8.8% | 8.1% | 8.1% | 8.2% | 8.0% | 8.3% | 8.2% | 8.3% | 8.0% | 8.0% | 7.6% | 6.9% | 7.6% | |
| 5.3% | 6.5% | 14.5% | 14.6% | 13.1% | 8.1% | 6.7% | 14.4% | 15.2% | -9.8% | 14.6% | 11.7% | 8.0% | |
| 1.4% | -27.7% | 2.2% | 2.5% | -9.6% | 1.3% | 0.9% | 5.3% | 5.2% | 3.8% | 4.6% | 4.8% | 4.6% | |
| 3.8% | 34.2% | 12.4% | 12.1% | 22.7% | 6.8% | 5.8% | 9.1% | 10.0% | -13.6% | 10.0% | 6.9% | 3.4% | |
| 18.1% | 18.3% | 26.6% | 26.9% | 25.4% | 21.4% | 21.5% | 28.2% | 28.7% | 4.3% | 28.1% | 23.8% | 21.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.